Search results
Moderna Inc [MRNA] Shares Fall
Knox Daily· 6 days agoGenuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA ...
Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton
The Wall Street Journal· 14 hours ago**Peloton Interactive (PTON)**: The fitness-equipment maker said Chief Executive Barry McCarthy was...
J.W. Cole Advisors Inc. Purchases 174 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 days agoCole Advisors Inc. lifted its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing ...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 3 days agoWe've identified 1 warning sign for Moderna that investors should be aware of in a dynamic business...
US stocks rise; Powell boosts sentiment ahead of Apple results By Investing.com
Investing.com· 1 day agoUS stocks rise; Powell boosts sentiment ahead of Apple results
Moderna: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 19 hours agoResearch was for a loss of $3.59 per share. The biotechnology company posted revenue of $167 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $124.7 ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 2 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks via Yahoo Finance· 3 days agoThe final step today is to look at a stock that meets our ESP qualifications. Moderna (MRNA) earns a...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 11 hours agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Moderna: Q1 Earnings Snapshot
The Woonsocket Call· 19 hours agoCAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $1.18 billion in its first quarter.
